MW032

· Mabwell (Shanghai) Bioscience Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MW032, covering 2023-02-24 to 2023-02-24. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of MW032 and Xgeva® in Subjects With Bone Metastases From Solid Tumors [Phase 3]